Literature DB >> 17350377

Prognostic significance of exercise induced arrhythmias and echocardiographic variables in hypertrophic cardiomyopathy.

T Jared Bunch1, Krishnaswamy Chandrasekaran, Jo-Ellen Ehrsam, Stephen C Hammill, Lynn H Urban, David O Hodge, Steve R Ommen, Patricia A Pellikka.   

Abstract

Hypertrophic cardiomyopathy (HC) often presents with exercise-induced symptoms, including arrhythmias and sudden death. The investigators prospectively studied whether exercise testing is associated with immediate complications and if stress-induced arrhythmias and echocardiographic variables are associated with long-term adverse outcomes. Exercise echocardiography with 6-channel continuous monitoring for arrhythmias was performed in consecutive patients with HC clinically referred for the test. End points included death, myocardial infarction, revascularization, stroke, atrial fibrillation, ventricular tachycardia, and myectomy. Of 86 patients with HC (mean age 56.6 +/- 16.1 years) who underwent exercise echocardiography, arrhythmias occurred in 39 (45%), including 23 (27%) with premature atrial contractions, 2 (2%) with atrial fibrillation, 28 (33%) with premature ventricular contractions (16 also had atrial arrhythmias), and 1 (1.2%) with nonsustained ventricular tachycardia (hemodynamically stable). During a follow-up of 2.6 +/- 2.8 years, major events occurred in 11 patients (3 deaths, 5 revascularizations, 3 strokes). In addition, 12 patients developed atrial fibrillation, 6 developed nonsustained ventricular tachycardia, and 13 underwent myectomies. Variables associated with major events included hypertension, male gender, and worsening wall motion score index with exercise; increased exercise duration was associated with fewer events. ST-T changes on baseline electrocardiography and premature ventricular contractions were associated with atrial fibrillation risk. In conclusion, in this cohort of patients with HC, exercise testing was safe. Test results were associated with risk for adverse events.

Entities:  

Mesh:

Year:  2007        PMID: 17350377     DOI: 10.1016/j.amjcard.2006.10.046

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  11 in total

1.  Exercise in hypertrophic cardiomyopathy.

Authors:  Sharlene M Day
Journal:  J Cardiovasc Transl Res       Date:  2009-10-14       Impact factor: 4.132

2.  33-year-old man with syncope.

Authors:  Seth H Sheldon; Nicholas M Orme; Kyle W Klarich
Journal:  Mayo Clin Proc       Date:  2011-07       Impact factor: 7.616

3.  Decreased exercise capacity and sleep-disordered breathing in patients with hypertrophic cardiomyopathy.

Authors:  Tomas Konecny; Jeffrey B Geske; Ondrej Ludka; Marek Orban; Peter A Brady; Muaz M Abudiab; Felipe N Albuquerque; Alexander Placek; Tomas Kara; Karine R Sahakyan; Bernard J Gersh; A Jamil Tajik; Thomas G Allison; Steve R Ommen; Virend K Somers
Journal:  Chest       Date:  2015-06       Impact factor: 9.410

4.  Safety profile and utility of treadmill exercise in patients with high-gradient hypertrophic cardiomyopathy.

Authors:  Lars Lindholm Sorensen; Hsin-Yueh Liang; Aurelio Pinheiro; Alex Hilser; Veronica Dimaano; Niels Thue Olsen; Thomas Fritz Hansen; Peter Sogaard; Alexandra Nowbar; Chiara Pisanello; Iraklis Pozios; Susan Phillip; Xun Zhou; Roselle Abraham; Theodore P Abraham
Journal:  Am Heart J       Date:  2016-10-20       Impact factor: 4.749

5.  Prognostic impact of atrial fibrillation in hypertrophic cardiomyopathy: a systematic review.

Authors:  Patricia Alphonse; Sohaib Virk; Jhonna Collins; Timothy Campbell; Stuart P Thomas; Christopher Semsarian; Saurabh Kumar
Journal:  Clin Res Cardiol       Date:  2020-09-03       Impact factor: 5.460

6.  The prevalence and the prognostic value of microvolt T-wave alternans in patients with hypertrophic cardiomyopathy.

Authors:  Ewa Trzos; Jarosław D Kasprzak; Maria Krzemińska-Pakuła; Tomasz Rechciński; Karina Wierzbowska-Drabik; Barbara Uznańska; Adam Śmiałowski; Tomasz Rudziński; Małgorzata Kurpesa
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-07       Impact factor: 1.468

Review 7.  Hypertrophic cardiomyopathy: genetics and clinical perspectives.

Authors:  Cordula Maria Wolf
Journal:  Cardiovasc Diagn Ther       Date:  2019-10

8.  Relationship between atrial fibrillation and blunted hyperemic myocardial blood flow in patients with hypertrophic cardiomyopathy.

Authors:  Roberto Sciagrà; Barbara Sotgia; Iacopo Olivotto; Franco Cecchi; Stefano Nistri; Paolo G Camici; Alberto Pupi
Journal:  J Nucl Cardiol       Date:  2009-01-20       Impact factor: 5.952

9.  EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations.

Authors:  Marco Guazzi; Volker Adams; Viviane Conraads; Martin Halle; Alessandro Mezzani; Luc Vanhees; Ross Arena; Gerald F Fletcher; Daniel E Forman; Dalane W Kitzman; Carl J Lavie; Jonathan Myers
Journal:  Circulation       Date:  2012-09-05       Impact factor: 29.690

10.  Exercise induced non-sustained ventricular tachycardia and indication for invasive management.

Authors:  Shahriar Dadkhah; Samaneh Dowlatshahi; Korosh Sharain; Roza Sharain
Journal:  Clin Med Insights Cardiol       Date:  2011-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.